Revance Therapeutics, Inc. (RVNC)
Feb 6, 2025 = RVNC was delisted (reason: acquired by Crown Laboratories)
3.650
0.00 (0.00%)
Inactive · Last trade price
on Feb 6, 2025
Revance Therapeutics Market Cap
Revance Therapeutics is not actively traded anymore. When Revance Therapeutics last traded, it had a market cap or net worth of $383.05 million.
Market Cap
383.05M
Enterprise Value
n/a
1-Year Change
-27.66%
Ranking
n/a
Category
Stock Price
$3.65
Market Cap Chart
Since February 6, 2014, Revance Therapeutics's market cap has decreased from $476.44M to $383.05M, a decrease of -19.60%. That is a compound annual growth rate of -1.96%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition